Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication

Background Neoadjuvant endocrine therapy (NET) can improve surgical outcomes in postmenopausal patients with hormone receptor-positive breast cancer. The Ki67 labelling index after NET has a better prognostic power than that at baseline. However, it remains unknown whether a multigene assay with pos...

Full description

Bibliographic Details
Main Authors: Hiroji Iwata, Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hironobu Sasano, Masakazu Toi
Format: Article
Language:English
Published: Elsevier 2019-02-01
Series:ESMO Open
Online Access:https://esmoopen.bmj.com/content/4/1/e000476.full

Internet

https://esmoopen.bmj.com/content/4/1/e000476.full

Similar Items